HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Submit a response Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hankins, C A Articles by O'Shaughnessy, M Search for Related Content PubMed PubMed Citation Articles by Hankins, C A Articles by O'Shaughnessy, M

HIV infection among women in prison: an assessment of risk factors using a nonnominal methodology.

C A Hankins, S Gendron, M A Handley, C Richard, M T Tung and M O'Shaughnessy

Centre for AIDS Studies, Montréal-Centre Regional Public Health Team, Québec, Canada.

The relative contributions of needle use practices and sexual behaviors to human immunodeficiency virus (HIV) antibody seropositivity among 394 women incarcerated in Quebec were determined by risk factor assessment and serology with a nonnominal methodology. HIV positivity was found in 6.9% (95% confidence interval [CI] = 4.6, 9.9) of all participants and in 13% (95% CI = 8.6, 18.6) of women with a history of injection drug use. HIV seropositivity among women with a history of injection drug use was predicted by sexual or needle contact with a seropositive person, self-reported genital herpes, and having had a regular sexual partner who injected drugs, but it was not predicted by prostitution. Nonnominal testing is an ethical alternative to mandatory and anonymous unlinked testing among correctional populations.

This article has been cited by other articles:

				D. Werb, T. Kerr, W. Small, K. Li, J. Montaner, and E. Wood HIV risks associated with incarceration among injection drug users: implications for prison-based public health strategies J. Public Health Med., June 1, 2008; 30(2): 126 - 132. [Abstract] [Full Text] [PDF]

				C. Poulin MSc, M. Alary MD PhD, G. Lambert MD, G. Godin PhD, S. Landry MA, H. Gagnon MA, E. Demers MSc, E. Morarescu MD MSc, J. Rochefort MSc, and C. Claessens MSc Prevalence of HIV and hepatitis C virus infections among inmates of Quebec provincial prisons Can. Med. Assoc. J., July 31, 2007; 177(3): 252 - 256. [Abstract] [Full Text] [PDF]

				L. Calzavara PhD, N. Ramuscak MSc, A. N. Burchell MSc, C. Swantee BSc, T. Myers PhD, P. Ford MD, M. Fearon MB, and S. Raymond RN Prevalence of HIV and hepatitis C virus infections among inmates of Ontario remand facilities Can. Med. Assoc. J., July 31, 2007; 177(3): 257 - 261. [Abstract] [Full Text] [PDF]

				M. Staton-Tindall, C. Leukefeld, J. Palmer, C. Oser, A. Kaplan, J. Krietemeyer, C. Saum, and H. L. Surratt Relationships and HIV Risk Among Incarcerated Women The Prison Journal, March 1, 2007; 87(1): 143 - 165. [Abstract] [PDF]

				B. K. Jordan, E. B. Federman, B. J. Burns, W. E. Schlenger, J. A. Fairbank, and J. M. Caddell Lifetime Use of Mental Health and Substance Abuse Treatment Services by Incarcerated Women Felons Psychiatr Serv, March 1, 2002; 53(3): 317 - 325. [Abstract] [Full Text] [PDF]

				H. E. Hutton, G. J. Treisman, W. R. Hunt, M. Fishman, N. Kendig, A. Swetz, and C. G. Lyketsos HIV Risk Behaviors and Their Relationship to Posttraumatic Stress Disorder Among Women Prisoners Psychiatr Serv, April 1, 2001; 52(4): 508 - 513. [Abstract] [Full Text] [PDF]